September 6th 2024
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
The ACP and Its Latest Guidelines on Type 2 Diabetes Mellitus: A View From the Trenches
February 18th 2012The American College of Physicians (ACP) has recently published its updated guidelines for type 2 diabetes mellitus (T2DM) management. While touted as "new," these guidelines offer no real breakthroughs in understanding. Our blogger offers a perspective; we’d like to hear yours.
New Additions to the Therapy Toolbox for Type 2 Diabetes: Incretins
October 29th 2010Type 2 diabetes mellitus is an epidemic with serious and fatal complications. Some predictions estimate that 440 million persons will have this disease by 2030. Current recommendations state that patients with type 2 diabetes who are receiving monotherapy and who have elevated hemoglobin A1c levels between 7.6% and 9.0% should receive a second agent.
Exercise Guidelines for Patients With Diabetes
October 6th 2010Your patient is a middle-aged man with type 2 diabetes who wants to start a weight-training program. What recommendations would you offer him? Another patient with diabetes has peripheral neuropathy; which types of exercise are safest for her? Answers to these and other questions about physical activity by patients who have diabetes mellitus can be found in guidelines from the American Diabetes Association. Highlights of those recommendations are presented here.
ACCORD Study Shows Mixed Results for Strict Glycemic Control
July 16th 2010Intensive control of blood glucose levels reduces the development and progression of certain microvascular complications of type 2 diabetes but does not reduce cardiovascular risk, according to the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study investigators.
Is Diabetes Control Like Goldilocks’ Porridge: What A1c Is Just Right?
June 17th 2010This generation’s diabetic control is preceded by the ever-present adjective “intensive.” Although a lower A1c seems to be a rational, and in many instances a proven target for type 2 diabetes with its constellation of micro- and macrovascular complications, are there downsides when prescribing exactly how low one’s A1c should go?
What's Race & Ethnicity Got To Do With It? For Insulin Regimens, A Lot
May 19th 2010Is a once daily dose of insulin glargine or NPH the best treatment strategy for patients who are of Latino/Hispanic descent? Which ethnicity responds best to a lispro mix of 75/25 twice daily? With the brunt of type 2 diabetes affecting non-Caucasian populations, researchers shed light on treatment strategy efficacy across races and ethnicities.
Diabetes Management: An Approach That Improves Outcomes and Reduces Costs
April 2nd 2008As many as 10% of Americans older than 20 years have type 2 diabetes, and more than 20% of the total population has the metabolic syndrome. Type 2 diabetes will develop in many of those with the metabolic syndrome.
Effective Diabetes Care: Closing In on an Elusive Goal
April 2nd 2008As the numbers of patients with diabetes continue to climb, physicians and health policy experts are devoting increasing attention to strategies that can improve care for these patients. One of the strategies frequently mentioned is the Chronic Care Model, developed in 1998 by the MacColl Institute for Healthcare Innovation.
For Better Glucose Monitoring, Attack the Finger on the Flank
April 2nd 2008Most patients who self-monitor their blood glucose levels stick the lancet into the finger pad to obtain a drop of blood for the glucometer. A more effective strategy is to stick the side of the finger instead. The sides are the most vascular areas on the finger, making it easier to obtain blood.
How Safe Is Alcohol for Patients With Diabetes?
March 1st 2007Alcohol ingestion is one of the most common causes of disabling hypoglycemiain the United States. The effects of alcohol ingestion onpatients with diabetes vary considerably, depending on whether they havetype 1 or type 2 diabetes and on whether they are receiving insulin therapy.